Island Pharmaceuticals LtdASX: ILA

Island receives FDA feedback on Phase 2a clinical study

Jan 20, 2023 at 4:12 AM UTC · Issued by Island Pharmaceuticals Ltd

Island Pharmaceuticals Ltd has released a press release.

View Attachment